期刊文献+

卡马西平治疗尿毒症性周围神经病变的临床疗效观察 被引量:2

Clinical efficacy of carbamazepine on treating uremic peripheral nervous lesion
下载PDF
导出
摘要 探讨卡马西平对尿毒症性周围神经病变的治疗作用。选择45例确诊尿毒症性周围神经病变的维持性血液透析尿毒症患者,随机分为治疗组(n=23)和对照组(n=22),分别给予卡马西平(100mg,每日3次)和安慰剂治疗8周;两组患者均每周行3次常规血液透析治疗。治疗前、治疗4周、治疗8周时分别观察两组患者周围神经病变的临床症状及正中神经、胫神经、腓总神经的感觉神经传导速度(SCV).治疗8周后,对照组患者周围神经病变的临床症状及感觉神经传导速度无明显改善。而治疗组患者周围神经病变的临床症状及感觉神经传导速度较治疗前有明显改善,其程度显著优于对照组(P<0.05).卡马西平能有效地改善尿毒症性周围神经病变。 Objective To evaluate the effect of carbamazepine in treatment of uremic peripheral nervous lesion.Methods Forty-five patients with uremic peripheral nervous lesion were selected and randomly divided into therapy group(n=23) and control group(n=22),receive respectively carbamazepine(100mg three times a day) and placebo treatment for eight weeks.All patients received regular hemodialysis thrice a week.The clinical symptoms and the sensory conduction velocity(SCV) of median nerve,tibial nerve and lateral popliteal nerve were measured in each group before,four weeks and eight weeks cost treatment respectively.Results After eight weeks treatment,the clinical symptoms,the nerve reflex and the SCV showed no obviously difference in control group,but significantly improvement in therapy group(P0.05).Conclusion Carbamazepine are effective for patients with uremic peripheral nervous lesion.
作者 曹炎生 詹悦
出处 《湖北师范学院学报(自然科学版)》 2012年第3期30-32,49,共4页 Journal of Hubei Normal University(Natural Science)
关键词 卡马西平 尿毒症 周围神经病变 感觉神经传导速度 carbamazepine uremia uremic peripheral nervous lesion sensory conduction velocity
  • 相关文献

参考文献6

二级参考文献17

  • 1王成,娄探奇,唐骅,陈珠江,石成钢,尹培达,余学清.常用血液净化方法对维持性血液透析患者血清甲状旁腺素的清除效果[J].中华急诊医学杂志,2005,14(1):61-63. 被引量:108
  • 2关玉珍.血液透析联合血液灌流治疗顽固性尿毒症性皮肤瘙痒[J].中国血液净化,2006,5(3):169-169. 被引量:70
  • 3杨国亮 王侠生.现代皮肤病学[M].上海:上海医科大学出版社,1998.504. 被引量:104
  • 4[1]Jurcic D,Bago J,Eljuga D.Features of uremic neuropathy in longterm dialysis.Coll Antropol,1998,22( 1 ):119-125 被引量:1
  • 5[2]Imam I,Salako BL,Akinola A.Peripheral neuropathy in Nigerian subjects with chronic renal failure.Niger J Med,2003,12(2):72-75 被引量:1
  • 6[3]Man NK,Cueille G,Zingraff J,et al.Uremic neurotoxin in the middle molecular weight range.Artif Organs,1980,4(2):116-120 被引量:1
  • 7[4]Dukanovic L.Middle molecular weight substances and uremic polyneuropathy.Acta Med Iugosl,1990,44(2):117-128 被引量:1
  • 8[5]Avram MM,Feinfeld DA,Huatuco AH.Search for the uremic toxin.Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.N Engl J Med,1978,298(18):1000-1003 被引量:1
  • 9[6]Aiello I,Serra G,Gilli P,et al.Uremic neuropathy:correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum.Eur Neurol,1982,21 (6):396-400 被引量:1
  • 10[7]Barats MS,Gonick HC,Rothenberg S,et al.Severe lead-induced peripheral neuropathy in a dialysis patient.Am J Kidney Dis,2000,35(5):963-968 被引量:1

共引文献254

同被引文献10

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部